Evidence map›Paper›PMID 40089789›Full record

ArticleCardio-oncology (London, England)2025

Principles of optimal multidisciplinary management of prostate cancer in clinical practice.

Filipe Cirne, Michiel Sedelaar, Vivek Narayan, Ariane Macedo, Christopher Koo, Jeffrey de Jesus, Anthony Ng, Diogo Bastos, Alberto Briganti, Susan F Dent and 4 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cardio-oncology (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Filipe CirneDepartment of Medicine and Population Health Research Institute, McMaster University, Hamilton, Canada.
Michiel SedelaarDepartment of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Vivek NarayanDepartment of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Ariane MacedoHospital Samaritano, São Paulo, Brazil.
Christopher KooBeth Israel Deaconess Medical Center, Boston, MA, USA.
Jeffrey de JesusSt. Luke's Medical Center Global City, Taguig, Philippines.
Anthony NgDepartment of Surgery, The Chinese University of Hong Kong, Shatin, Hong Kong, China.
Diogo BastosDepartment of Medical Oncology, Hospital Sirio Libanes, São Paulo, Brazil.
Alberto BrigantiVita-Salute San Raffaele University, Milan, Italy.
Susan F DentDivision of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Nishant P ShahDivision of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
Renato D LopesDivision of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. renato.lopes@duke.edu.
Daniel J LenihanDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Darryl P LeongDepartment of Medicine and Population Health Research Institute, McMaster University, Hamilton, Canada.

Funding

The webinar series was funded by Ferring Pharmaceuticals; there was no external funding for the manuscript. N/A
6 · The paper itself

Abstract

Advances in the diagnosis and management of prostate cancer have significantly changed the disease landscape. While benefiting from better oncological outcomes, patients are now experiencing higher rates of non-cancer comorbidities, including cardiovascular disease. The increasing impact of cardiovascular disease in those with prostate cancer led to the expanding role of cardio-oncology professionals in enhancing the multidisciplinary care of these patients. As a result, the International Cardio-Oncology Society (IC-OS) launched a 4-webinar series in collaboration with the European Association of Urology and the Canadian Urology Association to inform best practices in the multidisciplinary care of patients with prostate cancer. This program highlighted currently recommended diagnostic and treatment strategies from urology, oncology, and cardiology and emphasized knowledge gaps and future directions. In this article, which is the second in a 2-part series, we review challenging cases that were presented and discussed among a multidisciplinary international panel and highlight ongoing research and future directions from both urology/oncology and cardio-oncology.

Indexed as

Cardio-oncologyCardiovascular diseaseMultidisciplinary careProstate cancer

Identifiers

PMID40089789
PMCPMC11909940

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.